Explore a 10-minute conference talk from the Cancer Genomics Consortium (CGC) Annual Meeting that delves into chromosomal microarray analysis work-up for hypocellular MDS patients with inconclusive cytogenetics. Learn about the challenges and solutions in diagnosing myelodysplastic syndrome (MDS) cases where traditional cytogenetic methods may be insufficient. Gain insights into how advanced genomic testing techniques can improve diagnostic accuracy and potentially guide more targeted therapies for cancer patients. Understand the CGC's mission to promote best practices in clinical cancer genomics and their goal of ensuring accurate genomic diagnoses for all cancer patients to facilitate optimal treatment decisions.